Microbiome and Immunotherapy for NSCLC Podcast

Podcast | English | 2025 | 50 Min

Create Account

Cost

$0.00

Credit

No Credit Offered

This episode of Lung Cancer Considered takes an in-depth look at the microbiome-- what is it, and why is it important to lung cancer clinicians and researchers? The microbiome has been implicated in the pathogenesis of disease, but much is still unknown about it, including how and whether it affects patients with lung cancer.

Podcast Hosts:

Stephen Liu, MD, Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics, Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C., USA

Podcast Guests:

Arielle Elkrief, MD, Oncologue médicale + clinicienne-chercheuse, Université de Montréal, Canada
Bertrand Routy, MD, Director of the Laboratory of Immunotherapy and Oncomicrobiome, CRCHUM, Associate Clinical Professor, Université de Montréal, Canada